PT Enseval Putera Megatrading (EPMT) Fundamentals 2026 — P/E 8.1x, Revenue Analysis | SniperIQ
PT Enseval Putera Megatrading (EPMT) is a ID-listed Healthcare company in Medical - Distribution with a market capitalization of Rp6.28T, trading at Rp2320.00 on the JKT. This SniperIQ fundamentals page covers PT Enseval Putera Megatrading's valuation (P/E 8.1x, P/B 0.8x), profitability (net margin 2.3%), revenue (Rp32.96T in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is PT Enseval Putera Megatrading's market cap?
PT Enseval Putera Megatrading (EPMT) has a market capitalization of approximately Rp6.28T, trading at Rp2320.00 on the JKT. Market cap moves with the live share price.
What is PT Enseval Putera Megatrading's P/E ratio?
PT Enseval Putera Megatrading's trailing twelve-month P/E ratio is 8.1x, with a price-to-book (P/B) of 0.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is PT Enseval Putera Megatrading?
PT Enseval Putera Megatrading runs a net profit margin of 2.3%, a gross margin of 9.6%, and an operating margin of 3.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does PT Enseval Putera Megatrading generate?
PT Enseval Putera Megatrading reported revenue of Rp32.96T for fiscal year 2025, with net income of Rp789.2B and earnings per share (EPS) of 291.36. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does PT Enseval Putera Megatrading pay a dividend?
PT Enseval Putera Megatrading does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is PT Enseval Putera Megatrading financially healthy?
PT Enseval Putera Megatrading carries a debt-to-equity ratio of 0.00x and a current ratio of 2.09x, with a market beta of -0.03. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is PT Enseval Putera Megatrading a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For PT Enseval Putera Megatrading (EPMT) the key facts are: market cap Rp6.28T, P/E 8.1x, revenue Rp32.96T, 52-week range 2090-2460. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track PT Enseval Putera Megatrading's full fundamentals live
Get PT Enseval Putera Megatrading's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.